/R E P E A T -- Sirona Biochem to Exhibit at PCHi 2019 in Guanzhou China/

VANCOUVER, Feb. 26, 2019 /CNW/ -  Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (the "Company") announces that it will exhibit at The Personal Care and Homecare Ingredients trade show (PCHi 2019) in Guanzhou China Feb 26-28^th 2019. The PCHi 2019 trade show is China's #1 sourcing platform for the global personal care industry  https://www.pchi-china.com/en/. Sirona will be principally promoting its novel skin lightening agent TFC-1067 in addition to its anti-wrinkle and anti-aging compounds.

Sirona's business development team in China, will be supported by a large Chinese cosmetic distribution company. The distribution company is working closely with Sirona through a memorandum of understanding to establish an optimal pathway to commercialize TFC-1067 into the Chinese skin lightening market. The PCHi 2019 will introduce Sirona's technology to an estimated 75 cosmetic companies and numerous market experts. The business development team assembled has local knowledge and expertise that allows Sirona to navigate this immense opportunity.

Thanks to the efforts of PRC Partners Limited, Sirona has established a strong and experienced team with the diverse skill to navigate the optimal pathways to commercialize into this market.  The global skin lightening market is estimated to grow to US$31.2 billion by 2024¹. Asia makes up the largest and fastest growing segment of the market. 

Sirona would also like to thank the strong support for our recently announced financing which has been filed with the TSX Venture exchange. The Offering is subject to TSX Venture Exchange ("TSXV") final acceptance of requisite regulatory filings. When approved by the TSXV, a news release will be issued by the company.

About Sirona Biochem Corp.

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential.

Sirona's compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and ongoing royalty payments. Sirona's laboratory, TFChem, is in France and is the recipient of multiple French national scientific awards and European Union and French government grants. For more information, please visit www.sironabiochem.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Sirona Biochem cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. Forward-looking statements are only predictions based upon current expectations and involve known and unknown risks and uncertainties. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of release of the relevant information, unless explicitly stated otherwise.  Actual results, performance or achievement could differ materially from those expressed in, or implied by, Sirona Biochem's forward-looking statements due to the risks and uncertainties inherent in Sirona Biochem's business including, without limitation, statements about: the progress and timing of its clinical trials; difficulties or delays in development, testing, obtaining regulatory approval, producing and marketing its products; unexpected adverse side effects or inadequate therapeutic efficacy of its products that could delay or prevent product development or commercialization; the scope and validity of patent protection for its products; competition from other pharmaceutical or biotechnology companies; and its ability to obtain additional financing to support its operations. Sirona Biochem does not assume any obligation to update any forward-looking statements except as required by law.

_____________________
^1	(1) Global Industry Analysts (2018, March). Obsession with Lighter Skin Tones in Asia, the Middle East & Africa Drives Opportunities in the Global Skin Lighteners Market Retrieved from https://www.strategyr.com/MarketResearch/Skin_Lighteners_Market_Trends.asp

SOURCE Sirona Biochem Corp.

For further information: regarding this press release, please contact: Christopher Hopton, CFO, Sirona Biochem Corp., Email: [e-mail]